Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maryam Lustberg

Showing results (101-110 of 152) with videos related to

Pageof 16
Sort By:
Expert Review of Neurotherapeutics|December 13, 2021
Optimal outcome measures for assessing exercise and rehabilitation approaches in chemotherapy-induced peripheral-neurotoxicity: Systematic review and consensus expert opinionSusanna B Park, Stefano Tamburin, Angelo Schenone, et al.
Breast Cancer Research and Treatment|October 5, 2022
Patient-centered dosing: oncologists' perspectives about treatment-related side effects and individualized dosing for patients with metastatic breast cancer (MBC)Anne L Loeser, Lucy Gao, Aditya Bardia, et al.
JCO Oncology Practice|March 22, 2024
The Right Dose: Results of a Patient Advocate-Led Survey of Individuals With Metastatic Breast Cancer Regarding Treatment-Related Side Effects and Views About Dosage Assessment to Optimize Quality of LifeAnne Loeser, Janice S Kim, Jeffrey Peppercorn, et al.
Cancer Medicine|June 19, 2024
Real-world treatment patterns of adjuvant endocrine therapy and ovarian suppression in premenopausal HR+/HER2+ breast cancerJasmine S Sukumar, Sagar Sardesai, Andy Ni, et al.
Methods and Protocols|July 25, 2024
Protocol for the Development and Initial Validation of the COG-IMPACT Tool: A Purpose-Built Unmet Needs Assessment for Cancer-Related Cognitive ImpairmentDarren Haywood, Moira O'Connor, Frank D Baughman, et al.
Neuro-Oncology Advances|August 15, 2020
Multidisciplinary patient-centered management of brain metastases and future directionsJoshua D Palmer, Daniel M Trifiletti, Vinai Gondi, et al.
Cancers|May 27, 2026
Placebo Response in Phase II-III Symptom Intervention Studies: A Focus on Chemotherapy-Induced Peripheral Neuropathy and Associated Neuropathic PainDavid Zahrieh, Daniel Satele, Hiboombe Haamankuli, et al.
Psycho-Oncology|June 26, 2026
Advancing Dimensional Models of Psychopathology in Cancer: Insights From Applying the Hierarchical Taxonomy of Psychopathology (HiTOP)Darren Haywood, Jai Carmichael, Miriam K Forbes, et al.
Journal of the National Cancer Institute|February 6, 2016
Veliparib Alone or in Combination with Mitomycin C in Patients with Solid Tumors With Functional Deficiency in Homologous Recombination RepairMiguel A Villalona-Calero, Wenrui Duan, Weiqiang Zhao, et al.
Frontiers in Oncology|November 16, 2020
Estrogen Receptor Beta (ERβ): A Ligand Activated Tumor SuppressorRahul Mal, Alexa Magner, Joel David, et al.
Pageof 16

Showing results (101-110 of 152) with videos related to

Sort By:
Pageof 16
Expert Review of Neurotherapeutics|December 13, 2021
Optimal outcome measures for assessing exercise and rehabilitation approaches in chemotherapy-induced peripheral-neurotoxicity: Systematic review and consensus expert opinionSusanna B Park, Stefano Tamburin, Angelo Schenone, et al.
Breast Cancer Research and Treatment|October 5, 2022
Patient-centered dosing: oncologists' perspectives about treatment-related side effects and individualized dosing for patients with metastatic breast cancer (MBC)Anne L Loeser, Lucy Gao, Aditya Bardia, et al.
JCO Oncology Practice|March 22, 2024
The Right Dose: Results of a Patient Advocate-Led Survey of Individuals With Metastatic Breast Cancer Regarding Treatment-Related Side Effects and Views About Dosage Assessment to Optimize Quality of LifeAnne Loeser, Janice S Kim, Jeffrey Peppercorn, et al.
Cancer Medicine|June 19, 2024
Real-world treatment patterns of adjuvant endocrine therapy and ovarian suppression in premenopausal HR+/HER2+ breast cancerJasmine S Sukumar, Sagar Sardesai, Andy Ni, et al.
Methods and Protocols|July 25, 2024
Protocol for the Development and Initial Validation of the COG-IMPACT Tool: A Purpose-Built Unmet Needs Assessment for Cancer-Related Cognitive ImpairmentDarren Haywood, Moira O'Connor, Frank D Baughman, et al.
Neuro-Oncology Advances|August 15, 2020
Multidisciplinary patient-centered management of brain metastases and future directionsJoshua D Palmer, Daniel M Trifiletti, Vinai Gondi, et al.
Cancers|May 27, 2026
Placebo Response in Phase II-III Symptom Intervention Studies: A Focus on Chemotherapy-Induced Peripheral Neuropathy and Associated Neuropathic PainDavid Zahrieh, Daniel Satele, Hiboombe Haamankuli, et al.
Psycho-Oncology|June 26, 2026
Advancing Dimensional Models of Psychopathology in Cancer: Insights From Applying the Hierarchical Taxonomy of Psychopathology (HiTOP)Darren Haywood, Jai Carmichael, Miriam K Forbes, et al.
Journal of the National Cancer Institute|February 6, 2016
Veliparib Alone or in Combination with Mitomycin C in Patients with Solid Tumors With Functional Deficiency in Homologous Recombination RepairMiguel A Villalona-Calero, Wenrui Duan, Weiqiang Zhao, et al.
Frontiers in Oncology|November 16, 2020
Estrogen Receptor Beta (ERβ): A Ligand Activated Tumor SuppressorRahul Mal, Alexa Magner, Joel David, et al.
Pageof 16